OXOLife

SME

OXOLife

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem. Sign in

OXOLife

Address

Barcelona, Catalunya, Spain

Contact

info@oxolife.com

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem.

Matchmaking

Connect with OXOLife

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

OXOLife last news

13/11/2023

Oxolife Appoints International Fertility Experts to its Scientific Advisory Board

Barcelona, Spain – 13th November 2023, Oxolife, the specialist biotech focused on enhancing embryo implantation in women undergoing Assisted Reproductive Technology (ART) fertility treatment, today announces it has appointed globally renowned fertility experts to its Scientific Advisory Board (SAB).  There is a very large and growing global infertility market, with 76m women a year affected […] La entrada Oxolife Appoints International Fertility Experts to its Scientific Advisory Board se publicó primero en Oxolife .

27/03/2023

OXO-001, for embryo implantation makes headlines in the Daily News!

Oxolife and its phase II asset OXO-001 for embryo implantation have been featured in the UK's highest circulated daily newspaper. The Daily Mail calls the endometrium effect of OXO-001 "building a better womb lining nest" which translates into more live birth rates by providing the embryo with the right environment to progress. Link Daily News La entrada OXO-001, for embryo implantation makes headlines in the Daily News! se publicó primero en Oxolife .

10/10/2022

Oxolife in the radio

We are delighted to share the interview to our CEO Agnès Arbat on #Lideratges, Ariadna's Belver Comin program, where they have given voice to women who have entrepreneurial projects. ���� During the interview, OXOLIFE origins were presented, how Agnès and Ignasi Canals started from zero and then, thanks to loans such as Enisa, the start-up […] La entrada Oxolife in the radio se publicó primero en Oxolife .